Story perspectives

Isfahan Study Reveals Key Genes in PDAC and Diabetes

10/25/2025

Summary

Story summary

A study in Isfahan, Iran analyzed blood samples from 100 participants, including pancreatic ductal adenocarcinoma (PDAC), type 2 diabetes (T2D), and healthy controls.
Researchers used RNA sequencing and bioinformatics to identify differentially expressed genes and co-expression networks.
The team conducted RNA extraction, cDNA synthesis, and qPCR validation with statistical analyses across groups.
The University of Isfahan's ethics committee approved the study.
Results indicated significant findings relevant to PDAC and T2D.

1 of 1

Story summary

A study in Isfahan, Iran analyzed blood samples from 100 participants, including pancreatic ductal adenocarcinoma (PDAC), type 2 diabetes (T2D), and healthy controls.
Researchers used RNA sequencing and bioinformatics to identify differentially expressed genes and co-expression networks.
The team conducted RNA extraction, cDNA synthesis, and qPCR validation with statistical analyses across groups.
The University of Isfahan's ethics committee approved the study.
Results indicated significant findings relevant to PDAC and T2D.